DK1023904T3 - Adjuvanser til anvendelse i vacciner - Google Patents

Adjuvanser til anvendelse i vacciner

Info

Publication number
DK1023904T3
DK1023904T3 DK99310514T DK99310514T DK1023904T3 DK 1023904 T3 DK1023904 T3 DK 1023904T3 DK 99310514 T DK99310514 T DK 99310514T DK 99310514 T DK99310514 T DK 99310514T DK 1023904 T3 DK1023904 T3 DK 1023904T3
Authority
DK
Denmark
Prior art keywords
vaccines
adjuvants
Prior art date
Application number
DK99310514T
Other languages
Danish (da)
English (en)
Inventor
Don Alan Dearwester
Leroy Allen Swearingin
David Stewart Roberts
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of DK1023904T3 publication Critical patent/DK1023904T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/825—Bacterial vaccine for porcine species, e.g. swine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK99310514T 1999-01-29 1999-12-23 Adjuvanser til anvendelse i vacciner DK1023904T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11770599P 1999-01-29 1999-01-29
US12176099P 1999-02-26 1999-02-26

Publications (1)

Publication Number Publication Date
DK1023904T3 true DK1023904T3 (da) 2005-12-27

Family

ID=26815550

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99310514T DK1023904T3 (da) 1999-01-29 1999-12-23 Adjuvanser til anvendelse i vacciner
DK05023118.2T DK1616573T3 (da) 1999-01-29 1999-12-23 Bordetella bronchiseptica-vaccine

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK05023118.2T DK1616573T3 (da) 1999-01-29 1999-12-23 Bordetella bronchiseptica-vaccine

Country Status (17)

Country Link
US (6) US6572861B1 (de)
EP (2) EP1023904B1 (de)
JP (3) JP2000219636A (de)
CN (2) CN1449825B (de)
AR (2) AR035474A1 (de)
AT (2) ATE533504T1 (de)
AU (2) AU769539B2 (de)
BR (2) BRPI0000126B8 (de)
CA (2) CA2296244C (de)
CY (2) CY1105684T1 (de)
DE (1) DE69928763T2 (de)
DK (2) DK1023904T3 (de)
ES (2) ES2374628T3 (de)
HK (2) HK1030166A1 (de)
NZ (2) NZ502341A (de)
PT (1) PT1616573E (de)
TW (1) TW585777B (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US6676958B2 (en) * 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
US7279163B1 (en) * 2002-03-21 2007-10-09 The United States Of America, As Represented By The Secretary Of Agriculture Water-in-oil emulsion vaccines
NZ538394A (en) * 2002-08-26 2008-06-30 Pfizer Prod Inc Vaccine for respiratory and reproductive system infections in cattles
ES2303046T3 (es) * 2003-01-29 2008-08-01 Pfizer Products Inc. Vacunas caninas contra bordetella bronchiseptica.
PL1613346T3 (pl) * 2003-04-04 2013-03-29 Zoetis Services Llc Poddane mikrofluidyzacji emulsje typu olej w wodzie i kompozycje szczepionek
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
CN1323718C (zh) * 2004-03-15 2007-07-04 中国农业科学院兰州兽医研究所 一种利用植物油佐剂制备动物病毒性、细菌性疫苗的方法
FR2878746B1 (fr) * 2004-12-02 2007-02-23 Vetoquinol Sa Sa Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
CN1320924C (zh) * 2005-01-07 2007-06-13 邢为藩 一种自乳化疫苗佐剂及其制备方法
CA2637598A1 (en) 2006-01-18 2007-02-14 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
TR201807756T4 (tr) 2006-09-26 2018-06-21 Infectious Disease Res Inst Sentetik adjuvan içeren aşı bileşimi.
US20090181078A1 (en) * 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
NZ576563A (en) * 2006-11-03 2012-09-28 Alphavax Inc Alphavirus and alphavirus replicon particle formulations and methods
US20090017064A1 (en) * 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
CN106310293A (zh) 2007-09-27 2017-01-11 免疫疫苗技术有限公司 在包括连续疏水相的载体中的脂质体在体内输送多核苷酸中的应用
US20100209452A1 (en) * 2007-10-03 2010-08-19 Immunovaccine Technologies, Inc Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof
WO2009059328A2 (en) * 2007-11-02 2009-05-07 The Johns Hopkins University Multi- component l2 vaccine for prevention of human papillomavirus infection
CN101428145B (zh) * 2007-11-05 2013-01-02 北京生泰尔生物科技有限公司 新型疫苗佐剂
AU2009253780B2 (en) * 2008-06-05 2014-08-14 Immunovaccine Technologies Inc. Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
DK2310046T3 (da) 2008-06-27 2016-04-25 Zoetis Services Llc Hidtil ukendte adjuvanssammensætninger
AU2009302582A1 (en) 2008-10-06 2010-04-15 University Of Chicago Compositions and methods related to bacterial Eap, Emp, and/or AdsA proteins
KR101773368B1 (ko) 2009-04-03 2017-08-31 유니버시티 오브 시카고 단백질 Ａ(ＳｐＡ) 변이체와 관련된 조성물 및 방법
EP2437753B1 (de) 2009-06-05 2016-08-31 Infectious Disease Research Institute Synthetische glucopyranosyl-lipid-adjuvanzien und impfstoffzusammensetzungen die diese enthalten
US9241987B2 (en) 2009-11-20 2016-01-26 The University Of Chicago Methods and compositions related to immunogenic fibrils
US9849174B2 (en) 2009-11-20 2017-12-26 The Board Of Regents Of The University Of Texas System Methods and compositions related to immunogenic fibrils
WO2011100508A2 (en) 2010-02-12 2011-08-18 Arizona Board Of Regents For And On Behalf Of Arizona State University Methods and compositions related to glycoprotein-immunoglobulin fusions
CN102946900A (zh) 2010-03-11 2013-02-27 免疫设计公司 用于大流行流感的疫苗
JP2013523818A (ja) 2010-04-05 2013-06-17 ザ・ユニバーシティー・オブ・シカゴ 免疫反応のエンハンサーとしてのプロテインＡ（ＳｐＡ）抗体に関連する組成物および方法
US20120003298A1 (en) 2010-04-30 2012-01-05 Alcide Barberis Methods for inducing an immune response
EP2563404B1 (de) 2010-04-30 2016-09-21 Urogen Pharma Ltd. Phospholipid-wirkstoffanaloga
US9050319B2 (en) 2010-04-30 2015-06-09 Telormedix, Sa Phospholipid drug analogs
CN103037885B (zh) 2010-07-02 2015-08-26 芝加哥大学 与蛋白A(SpA)变体相关的组合物和方法
JP5793194B2 (ja) 2010-09-09 2015-10-14 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ 感染防御ブドウ球菌抗原が関与する方法および組成物
JP5865839B2 (ja) * 2010-09-28 2016-02-17 共立製薬株式会社 粘膜アジュバント組成物
AU2012243039B2 (en) 2011-04-08 2017-07-13 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
US20120288515A1 (en) 2011-04-27 2012-11-15 Immune Design Corp. Synthetic long peptide (slp)-based vaccines
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
EP2763698B1 (de) 2011-10-06 2020-12-02 ImmunoVaccine Technologies Inc. Liposomzusammensetzungen mit einem adjuvans zur aktivierung oder steigerung der aktivität von tlr2 und verwendungen davon
GB201205237D0 (en) 2012-03-26 2012-05-09 Univ Edinburgh Adjuvant
EP2844275B1 (de) 2012-04-26 2020-05-13 University of Chicago Staphylokokken-coagulase-antigene und verfahren zu deren verwendung
RS57420B1 (sr) 2012-05-16 2018-09-28 Immune Design Corp Vakcine za hsv-2
PL2943219T4 (pl) 2012-09-10 2022-08-22 Susan Szathmary Szczepionka do zapobiegania zakażeniu mykoplazmalnemu u ptactwa wodnego
CA2881863A1 (en) 2012-10-01 2014-04-10 Telormedix Sa Phospholipid drug analogs
CA2909221A1 (en) 2013-04-18 2014-10-23 Immune Design Corp. Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
EP3954385A1 (de) 2014-07-11 2022-02-16 Zoetis Services LLC Neuartige impfstoffzusammensetzungen gegen das porcine epidemische diarrhoevirus
JP6824177B2 (ja) 2015-02-27 2021-02-03 アイオア・ステート・ユニバーシティー・リサーチ・ファンデーション・インコーポレーテッドＩｏｗａ Ｓｔａｔｅ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ Ｉｎｃｏｒｐｏｒａｔｅｄ 豚流行性下痢ウイルス株及びそれから得られる免疫原性組成物
WO2017123201A1 (en) 2016-01-11 2017-07-20 Zoetis Services Llc Novel cross protective vaccine compositions for porcine epidemic diarrhea virus
BR112018069371A2 (pt) 2016-03-21 2019-01-22 South Dakota Board Of Regents construção de ácido nucleico, vetor, vacina ou composição imunogênica, método de entrega de uma vacina, método de produção de uma construção de ácido nucleico e método para conferir imunidade contra um antígeno
US11246924B2 (en) 2016-04-01 2022-02-15 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
US10662226B2 (en) 2016-10-28 2020-05-26 The Regents of the University of Caiifomia Synthetic beta-amyloid peptides capable of forming stable antigenic oligomers
GB201703529D0 (en) 2017-03-06 2017-04-19 Cambridge Entpr Ltd Vaccine composition
CN107027749B (zh) * 2017-05-24 2021-04-09 浙江工业大学 一种复合乳化剂及其在复配毒死蜱农药中的应用
ES2705378A1 (es) * 2017-09-22 2019-03-22 Decco Worldwide Post Harvest Holdings B V Metodo para el tratamiento y control de fisiopatias de postcosecha de frutas mediante recubrimientos comestibles.
US11413336B2 (en) 2018-03-23 2022-08-16 Board Of Regents, The University Of Texas System Coccidioides antigens and methods of their use
WO2020044267A1 (en) 2018-08-29 2020-03-05 Centre Hospitalier Universitaire Vaudois Ebola vaccine compositions and methods of using same
US11208167B2 (en) 2018-11-15 2021-12-28 Kuat Innovations Llc Bicycle rack with actuated arm
CN114315985A (zh) 2020-09-29 2022-04-12 硕腾服务有限责任公司 减毒猪流行性腹泻病毒
CN115216451A (zh) 2021-04-16 2022-10-21 硕腾服务有限责任公司 伪狂犬病病毒疫苗
TW202327646A (zh) 2021-10-15 2023-07-16 美商輝瑞大藥廠 Rna分子
CN113907044A (zh) * 2021-11-09 2022-01-11 福建省连江县刘氏兔业养殖场 一种抗病猪品系的培育方法及其应用
CA3242476A1 (en) 2021-12-17 2023-06-22 Pfizer Inc. Polynucleotide compositions and uses thereof
WO2023144779A1 (en) 2022-01-28 2023-08-03 Pfizer Inc. Coronavirus antigen variants
WO2024089634A1 (en) 2022-10-27 2024-05-02 Pfizer Inc. Immunogenic compositions against influenza and rsv
TW202424187A (zh) 2022-10-27 2024-06-16 美商輝瑞大藥廠 Rna分子
US20240252612A1 (en) 2022-12-11 2024-08-01 Pfizer Inc. Immunogenic compositions and uses thereof
CN118267462A (zh) 2022-12-29 2024-07-02 硕腾服务有限责任公司 接种猪以抗伪狂犬病病毒的方法
WO2024154052A1 (en) 2023-01-16 2024-07-25 Pfizer Inc. Immunogenic compositions and methods of inducing an immune response against varicella zoster virus

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
AT350181B (de) 1977-05-04 1979-05-10 Schuller Walter Dr Verfahren zur herstellung einer mischvaccine
US4137115A (en) * 1977-11-07 1979-01-30 Patrick Lambert Joining structure
US4237115A (en) * 1977-11-23 1980-12-02 Bactex, Inc. Method of immunization against enterotoxogenic infection by Escherichia coli
US4261925A (en) 1978-04-05 1981-04-14 The Dow Chemical Company Surfactants
US4504275A (en) 1983-03-24 1985-03-12 Imperial Chemical Industries Plc Emulsifying agents
US4606918A (en) 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4933179A (en) 1983-08-22 1990-06-12 Syntex (U.S.A.) Inc. Feline leukemia virus antigen vaccines
US5338748A (en) 1985-01-18 1994-08-16 Cetylite Industries, Inc. Sterilant composition
US5424323A (en) * 1985-01-18 1995-06-13 Cetylite Industries, Inc. Sterilant composition
DE3517805A1 (de) 1985-05-17 1986-11-20 Bayer Ag, 5090 Leverkusen Impfstoff zur immunisierung von schweinen gegen rhinitis atrophicans (schnueffelkrankheit)
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
US4789544A (en) * 1986-05-23 1988-12-06 Midcon Labs. Inc. Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation
US5019388A (en) * 1986-10-14 1991-05-28 Norden Laboratories Inc. Bordetella bronchiseptica vaccine
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
US5084269A (en) * 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
US5209929A (en) * 1987-03-19 1993-05-11 Washington State University Research Foundation Immunization against Babesiosis using purified merozoite surface antigens of Basesia bigemina
US5376369A (en) 1987-11-03 1994-12-27 Syntex (U.S.A.) Inc. Vaccine adjuvant
US5069901A (en) * 1988-02-03 1991-12-03 Jones Elaine V Preparation of a recombinant subunit vaccine against pseudorabies infection
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
FR2649012B1 (fr) * 1989-07-03 1991-10-25 Seppic Sa Emulsions multiphasiques injectables
US5223253A (en) * 1989-09-28 1993-06-29 American Home Products Corporation Bovine vaccine compositions and method for preventing trichomonas infections using same
EP0515415B1 (de) * 1990-02-12 1995-10-18 SMITHKLINE BEECHAM BIOLOGICALS s.a. Impfstoff
US5578308A (en) * 1990-02-12 1996-11-26 Capiau; Carine Glutaraldehyde and formalin detoxified bordetella toxin vaccine
WO1991018627A1 (en) * 1990-05-29 1991-12-12 Smithkline Beecham Corporation Swine pneumonia vaccine and method for the preparation thereof
DE69131525T2 (de) 1990-06-13 1999-11-25 Pfizer Inc., New York Pasteurella multocida toxoid enthaltende impfstoffe
US5695769A (en) * 1990-06-13 1997-12-09 Pfizer Inc. Pasteurella multocida toxoid vaccines
US5242686A (en) * 1990-11-07 1993-09-07 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
ES2194841T3 (es) 1991-11-15 2003-12-01 Pfizer Procedimiento de produccion de vacunas bacterianas gram negativas.
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5422277A (en) * 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
DE4222153C2 (de) 1992-07-06 1998-12-03 Peter Siegfried Verfahren zur Entölung von Rohlecithin
EP0626452B1 (de) * 1993-05-17 1999-08-11 Akzo Nobel N.V. Impstoff gegen Streptococcus suis-Infektion
AU5543294A (en) * 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
NZ281797A (en) * 1994-02-18 1997-04-24 Innovac Co Inoculation of animals by inserting dried pelleted biological materials into the animal's ear
DK53595A (da) * 1994-05-13 1995-11-14 Iberica Cyanamid Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner
DE69531690T2 (de) * 1994-06-10 2004-07-08 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Reinigungsverfahren für von bordetella bronchiseptica produziertes dermonekrotisches toxin
US5538733A (en) * 1994-07-07 1996-07-23 Willmar Poultry Company, Inc. Method of priming an immune response in a one-day old animal
US5625038A (en) * 1994-07-27 1997-04-29 Henderson; Louise M. Monoclonal antibodies specific for Erysipelothrix rhusiopathiae
US5603951A (en) 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
GB9620795D0 (en) 1996-10-05 1996-11-20 Smithkline Beecham Plc Vaccines
US5877298A (en) * 1995-05-04 1999-03-02 Connaught Lab Acellular pertussis vaccines and methods of preparing thereof
US5690942A (en) * 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
US5718904A (en) * 1995-06-02 1998-02-17 American Home Products Corporation Adjuvants for viral vaccines
US5814321A (en) 1995-11-30 1998-09-29 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Oil adjuvant vaccine and method for preparing same
DE69704011T2 (de) 1996-10-09 2001-06-07 Akzo Nobel Nv Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Sweins (PRRSV)
ZA982870B (en) * 1997-04-10 1998-10-09 Akzo Nobel Nv Live attenuated bacteria of the species actinobacillus pleuropneumoniae
US6517843B1 (en) * 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US6585981B1 (en) 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae

Also Published As

Publication number Publication date
EP1023904B1 (de) 2005-12-07
BRPI0000126B8 (pt) 2022-05-10
EP1616573B1 (de) 2011-11-16
BR0000126A (pt) 2001-05-02
ATE533504T1 (de) 2011-12-15
NZ502341A (en) 2001-08-31
DK1616573T3 (da) 2012-01-30
US6814971B2 (en) 2004-11-09
US7393535B2 (en) 2008-07-01
TW585777B (en) 2004-05-01
ES2374628T3 (es) 2012-02-20
BRPI0000126B1 (pt) 2015-07-14
NZ513202A (en) 2003-02-28
CA2296244A1 (en) 2000-07-29
PT1616573E (pt) 2012-01-11
CN1126568C (zh) 2003-11-05
CN1270838A (zh) 2000-10-25
AU2004201021A1 (en) 2004-04-08
AR055422A2 (es) 2007-08-22
US20030175299A1 (en) 2003-09-18
AR035474A1 (es) 2004-06-02
ATE311900T1 (de) 2005-12-15
CA2455134A1 (en) 2000-07-29
CN1449825B (zh) 2012-08-22
EP1616573A3 (de) 2007-05-09
CA2296244C (en) 2004-04-27
US6733754B2 (en) 2004-05-11
AU769539B2 (en) 2004-01-29
US20050058667A1 (en) 2005-03-17
DE69928763D1 (de) 2006-01-12
EP1023904A2 (de) 2000-08-02
JP4785365B2 (ja) 2011-10-05
JP2005041883A (ja) 2005-02-17
EP1023904A3 (de) 2002-08-21
HK1030166A1 (en) 2001-04-27
CN1449825A (zh) 2003-10-22
EP1616573A2 (de) 2006-01-18
CY1112521T1 (el) 2015-12-09
JP2000219636A (ja) 2000-08-08
US20030175309A1 (en) 2003-09-18
BRPI0017566B1 (pt) 2015-11-10
JP5167469B2 (ja) 2013-03-21
ES2251164T3 (es) 2006-04-16
US20030175308A1 (en) 2003-09-18
US20030175298A1 (en) 2003-09-18
AU6537299A (en) 2000-08-03
CY1105684T1 (el) 2010-12-22
CA2455134C (en) 2010-05-11
HK1059739A1 (en) 2004-07-16
DE69928763T2 (de) 2006-06-29
JP2004002479A (ja) 2004-01-08
US6572861B1 (en) 2003-06-03

Similar Documents

Publication Publication Date Title
DK1023904T3 (da) Adjuvanser til anvendelse i vacciner
NO20014322L (no) Vaksine
NO20031483L (no) Vaksine
DE60045324D1 (de) Impfstoffzusammensetzung
DK1210113T3 (da) Kombinerede vaccinepræparater
NO20024172D0 (no) Vaksine
NO20021433L (no) Vaksiner
NO20026175L (no) Vaksinesammensetning
NO20023674L (no) Regulerbar stol
ID26056A (id) Popok sekali pakai
PT1060695E (pt) Cadeira empilhavel
DE60002650D1 (de) Öladjuvierter Impfstoff
DZ3219A1 (fr) Vaccin
DK1265633T3 (da) Vaccineadjuvans
ID24782A (id) Popok sekali pakai
ID25571A (id) Popok sekali pakai
ATE519775T1 (de) Rekombinante untereinheiten-impfstoffe
NO20023517D0 (no) Stol
NO20003763L (no) Regulerbar stol
FI19992468A (fi) Tuoli
ZA200000142B (en) Adjuvants for use in vaccines.
FR2797166B1 (fr) Fauteuil reglable
NO20002213L (no) Babesia vaksine
AU2003204726A1 (en) Adjuvants for Use in Vaccines
DK199900124U3 (da) Bærbar stol